In-Person Access Only | 1.50 CE/CME Credits

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The Cancer Updates GU & Lung Las Vegas Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GU and Lung Cancers. The agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.

Conference Agenda
Thursday, March 4, 2027

Program Chairs:
Oscar Goodman, MD, PhD | Nevada Oncology Specialists

5:30 PM - 6:00 PM
Networking and Cocktails

6:00 PM - 6:05 PM
Welcome and Opening Remarks

6:05 PM - 6:35 PM
GU Cancer Updates
Oscar Goodman, MD, PhD | Nevada Oncology Specialists

6:35 PM - 6:55 PM
GU Cancer Panel Discussion
Oscar Goodman, MD, PhD | Nevada Oncology Specialists (Moderator)
Kyaw Zin Thein, MD | Comprehensive Cancer Centers

6:55 PM - 7:10 PM
Buffet and Exhibits

7:10 PM - 7:55 PM
Non CME Dinner - Pfizer Mevrometostat

7:55 PM - 8:05 PM
Desserts and Cocktails

8:05 PM - 8:35 PM
Lung Cancer Updates

8:35 PM - 8:55 PM
Lung Cancer Panel Discussion

8:55 PM
ADJOURN

Agenda Subject To Change. All times are PST.

• Learning Objectives

  • Review recent clinical advances in the treatment of genitourinary (GU) and lung cancers, with a focus on the most relevant data from recent studies and clinical trials.

  • Evaluate the role of emerging therapies in GU and lung cancer treatment, including new medications, targeted therapies, and immunotherapies.

  • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

  • Assess and manage side effects and toxicities associated with current and emerging therapies in GU and lung cancer patients.

  • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GU and lung cancers.

• Accreditation Information | 1.50 CE/CME Credits

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program